Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13852 ◽

2019 ◽

Vol 21 (12) ◽

pp. 2651-2659 ◽

Author(s):

Anna Norhammar ◽

Johan Bodegard ◽

Thomas Nyström ◽

Marcus Thuresson ◽

Klas Rikner ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Healthcare Costs ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

P6425Cardiovascular outcome in type 2 diabetes patients: impact of prior acute cardiac event or stroke vs. coronary artery disease: a Swedish nationwide observational study

European Heart Journal ◽

10.1093/eurheartj/ehy566.p6425 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

T Jernberg ◽

D Lindholm ◽

B Svennblad ◽

L P Hasvold ◽

J Bodegard ◽

...

Keyword(s):

Type 2 Diabetes ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Observational Study ◽

Cardiac Event ◽

Artery Disease ◽

Nationwide Observational Study ◽

Acute Cardiac Event ◽

Diabetes Patients

Download Full-text

PDB118 OUTCOMES AND HEALTHCARE COSTS FOR PATIENTS WITH TYPE 2 DIABETES UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN: A NATIONWIDE OBSERVATIONAL STUDY

Value in Health ◽

10.1016/j.jval.2019.09.1000 ◽

2019 ◽

Vol 22 ◽

pp. S594

Author(s):

A. Norhammar ◽

D. Erlinge ◽

L.P. Hasvold ◽

J. Bodegård ◽

P. Kritikou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Percutaneous Coronary Intervention ◽

Observational Study ◽

Healthcare Costs ◽

Coronary Intervention ◽

Elective Percutaneous Coronary Intervention ◽

Percutaneous Coronary ◽

Nationwide Observational Study

Download Full-text

Author response for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v2/response1 ◽

2019 ◽

Author(s):

Anna Norhammar ◽

Johan Bodegard ◽

Thomas Nyström ◽

Marcus Thuresson ◽

Klas Rikner ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Author Response ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v1/review5 ◽

2019 ◽

Author(s):

Rishab Gupta

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v1/review4 ◽

2019 ◽

Author(s):

Michael L. Ganz

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Decision letter for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text

Review for "Dapagliflozin vs Non‐SGLT‐2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE‐TIMI 58 Participants: A Nationwide Observational Study"

10.1111/dom.13852/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Hospital Care ◽

Nationwide Observational Study ◽

Diabetes Patients

Download Full-text